Hi All,
While I believe IMU could go down the path and develop a monotherapy/vaccine to treat or prevent cancer I don’t think that’s the best strategy as it would simply be butting heads with every BP on the planet and enough has been said already about their business ethics.
IMU already has indicated they’ll be taking a softly softly approach and test their platforms in combo with existing approved drugs from BP, a smart business move which means harmony is maintained, IMU platforms are through to market via licensing agreements and royalties, all parties are satisfied and patients are getting the benefits.
Just my opinion and I’m probably wrong but I don’t want to see IMU butting heads with BP.
Also FWIW, if/when IMU announces a successful P2 result and a revenue deal with BP all these trolls will disappear, there will be no congratulations however say we were right and they were wrong, it’s not how they’re wired.
- Forums
- ASX - By Stock
- IMU
- The CF33, Vaxinia and Oncarlytics Deal
IMU
imugene limited
Add to My Watchlist
13.6%
!
1.3¢

The CF33, Vaxinia and Oncarlytics Deal, page-305
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.002(13.6%) |
Mkt cap ! $93.33M |
Open | High | Low | Value | Volume |
1.2¢ | 1.4¢ | 1.1¢ | $586.4K | 47.53M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 8177557 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3447025 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 7625794 | 0.012 |
44 | 15645832 | 0.011 |
122 | 36046491 | 0.010 |
38 | 20531668 | 0.009 |
14 | 4320747 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3622884 | 27 |
0.014 | 12582139 | 47 |
0.015 | 6453614 | 23 |
0.016 | 6333321 | 29 |
0.017 | 7081669 | 12 |
Last trade - 15.07pm 27/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online